...
search icon
imdx-img

Insight Molecular Diagnostics Inc., Common Stock

IMDX

NAQ

$2.85

-$0.19

(-6.25%)

1D

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$91.52M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
0
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.92 L
$4.75 H
$2.85

About Insight Molecular Diagnostics Inc., Common Stock

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. The company also offers VitaGraft Kidney, a blood-based transplant monitoring test that quantifies the concentration of donor-derived cell-free DNA for kidney transplantation; VitaGraft Liver, a blood-based transplant monitoring test that quantifies the concentration of donor-derived cell-free DNA for liver transplantation; and GraftAssure, a dd-cfDNA test that uses droplet digital PCR technology to measure the concentration of dd-cfDNA using 48 predefined SNPs. In addition, it provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. for the development and commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. Insight Molecular Diagnostics Inc. was formerly known as OncoCyte Corporation and changed its name to Insight Molecular Diagnostics Inc. in June 2025. Insight Molecular Diagnostics Inc. was incorporated in 2009 and is based in Irvine, California. more

Returns

Data is not properly formatted.

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue1.22M7.73M958.00K1.50M1.88M[{"date":"2020-12-31","value":15.74,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":12.4,"profit":true},{"date":"2023-12-31","value":19.45,"profit":true},{"date":"2024-12-31","value":24.34,"profit":true}]
Cost of Revenue1.85M7.54M976.00K1.09M1.14M[{"date":"2020-12-31","value":24.61,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":12.95,"profit":true},{"date":"2023-12-31","value":14.46,"profit":true},{"date":"2024-12-31","value":15.13,"profit":true}]
Gross Profit(639.00K)188.00K(18.00K)413.00K740.00K[{"date":"2020-12-31","value":-86.35,"profit":false},{"date":"2021-12-31","value":25.41,"profit":true},{"date":"2022-12-31","value":-2.43,"profit":false},{"date":"2023-12-31","value":55.81,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin(52.55%)2.43%(1.88%)27.48%39.34%[{"date":"2020-12-31","value":-133.57,"profit":false},{"date":"2021-12-31","value":6.18,"profit":true},{"date":"2022-12-31","value":-4.78,"profit":false},{"date":"2023-12-31","value":69.85,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses33.08M47.13M30.31M25.64M60.64M[{"date":"2020-12-31","value":54.55,"profit":true},{"date":"2021-12-31","value":77.73,"profit":true},{"date":"2022-12-31","value":49.99,"profit":true},{"date":"2023-12-31","value":42.28,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(29.71M)(46.95M)(18.00M)(25.14M)(61.04M)[{"date":"2020-12-31","value":-2971100000,"profit":false},{"date":"2021-12-31","value":-4694600000,"profit":false},{"date":"2022-12-31","value":-1799700000,"profit":false},{"date":"2023-12-31","value":-2513600000,"profit":false},{"date":"2024-12-31","value":-6104100000,"profit":false}]
Total Non-Operating Income/Expense-645.00K(698.00K)229.00K294.00K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-108.22,"profit":false},{"date":"2023-12-31","value":35.5,"profit":true},{"date":"2024-12-31","value":45.58,"profit":true}]
Pre-Tax Income(31.19M)(73.36M)(18.61M)(24.86M)(60.66M)[{"date":"2020-12-31","value":-3118600000,"profit":false},{"date":"2021-12-31","value":-7335800000,"profit":false},{"date":"2022-12-31","value":-1861200000,"profit":false},{"date":"2023-12-31","value":-2485500000,"profit":false},{"date":"2024-12-31","value":-6066300000,"profit":false}]
Income Taxes(1.25M)(9.26M)54.83M--[{"date":"2020-12-31","value":-2.29,"profit":false},{"date":"2021-12-31","value":-16.89,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes-(64.10M)(73.44M)--[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-6409700000,"profit":false},{"date":"2022-12-31","value":-7344000000,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations-(43.61M)(18.61M)(24.86M)(60.66M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-4361000000,"profit":false},{"date":"2022-12-31","value":-1861200000,"profit":false},{"date":"2023-12-31","value":-2485500000,"profit":false},{"date":"2024-12-31","value":-6066300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(29.93M)(64.10M)(73.44M)(27.78M)(60.66M)[{"date":"2020-12-31","value":-2993200000,"profit":false},{"date":"2021-12-31","value":-6409700000,"profit":false},{"date":"2022-12-31","value":-7344000000,"profit":false},{"date":"2023-12-31","value":-2778100000,"profit":false},{"date":"2024-12-31","value":-6066300000,"profit":false}]
EPS (Diluted)(9.17)(14.09)--(31.49)[{"date":"2020-12-31","value":-917.34,"profit":false},{"date":"2021-12-31","value":-1409.37,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-3148.62,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

IMDX
Cash Ratio 3.20
Current Ratio 3.75
Quick Ratio 3.70

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IMDX
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

IMDX
Debt Ratio Lower is generally better. Negative is bad. 0.83
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.17

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IMDX
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
EV/R 0.00
EV/Ebitda NM

FAQs

What is Insight Molecular Diagnostics Inc. share price today?

Insight Molecular Diagnostics Inc. (IMDX) share price today is $2.85

Can Indians buy Insight Molecular Diagnostics Inc. shares?

Yes, Indians can buy shares of Insight Molecular Diagnostics Inc. (IMDX) on Vested. To buy Insight Molecular Diagnostics Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IMDX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Insight Molecular Diagnostics Inc. be purchased?

Yes, you can purchase fractional shares of Insight Molecular Diagnostics Inc. (IMDX) via the Vested app. You can start investing in Insight Molecular Diagnostics Inc. (IMDX) with a minimum investment of $1.

How to invest in Insight Molecular Diagnostics Inc. shares from India?

You can invest in shares of Insight Molecular Diagnostics Inc. (IMDX) via Vested in three simple steps:

  • Click on Sign Up or Invest in IMDX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Insight Molecular Diagnostics Inc. shares
What is Insight Molecular Diagnostics Inc. 52-week high and low stock price?

The 52-week high price of Insight Molecular Diagnostics Inc. (IMDX) is $4.75. The 52-week low price of Insight Molecular Diagnostics Inc. (IMDX) is $1.92.

What is Insight Molecular Diagnostics Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Insight Molecular Diagnostics Inc. (IMDX) is 0.00

What is the Market Cap of Insight Molecular Diagnostics Inc.?

The market capitalization of Insight Molecular Diagnostics Inc. (IMDX) is $91.52M

What is Insight Molecular Diagnostics Inc.’s stock symbol?

The stock symbol (or ticker) of Insight Molecular Diagnostics Inc. is IMDX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top